Free Trial

HedgePath Pharmaceuticals (HPPI) SEC Filings & 10K Form

$0.06 -0.01 (-17.39%)
(As of 12/20/2024 ET)

Recent HedgePath Pharmaceuticals SEC Filings

DateFilerForm TypeView
11/12/2024
5:27 AM
HedgePath Pharmaceuticals (Filer)
Inhibitor Therapeutics, Inc. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/06/2024
8:30 AM
HedgePath Pharmaceuticals (Filer)
Inhibitor Therapeutics, Inc. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/16/2024
12:34 PM
HedgePath Pharmaceuticals (Issuer)
Inhibitor Therapeutics, Inc. (Issuer)
Jerman Michael Allen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2024
12:34 PM
HedgePath Pharmaceuticals (Issuer)
Inhibitor Therapeutics, Inc. (Issuer)
OSMAN RONALD E (Reporting)
Ronald E Osman Irrevocable Trust III (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2024
12:34 PM
HedgePath Pharmaceuticals (Issuer)
Inhibitor Therapeutics, Inc. (Issuer)
SEARS SAMUEL P JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2024
12:34 PM
HedgePath Pharmaceuticals (Issuer)
Inhibitor Therapeutics, Inc. (Issuer)
MCNULTY JAMES A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2024
12:34 PM
HedgePath Pharmaceuticals (Issuer)
Inhibitor Therapeutics, Inc. (Issuer)
Yanez Michelle (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2024
8:00 AM
HedgePath Pharmaceuticals (Filer)
Inhibitor Therapeutics, Inc. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (OTCMKTS:HPPI) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners